The infamous “valley of death” is a bleak place for intellectual property. Fortunately, the University of Minnesota’s Committee for Pharmaceutical Development (CPD) has been created to guide researchers through the valley and bring life-altering drugs to market.

Want to learn how to boost the success rate of therapeutic development and commercialization? Join the Committee for Pharmaceutical Development for an upcoming workshop.

The Office for Technology Commercialization has launched a new Committee for Pharmaceutical Development (CPD) with the goal of identifying, developing and commercializing pharmaceutical products with the greatest impact.

The Office for Technology Commercialization is pleased to announce the launch of Eli Lilly’s Open Innovation Drug Discovery platform to the University of Minnesota research community.

Kenneth Kaitin is Director of the Center for the Study of Drug Development, Tufts University Strategy Clinic Seminars will be offered periodically as part of the Pharmaceutical Commercialization Initiative. These seminars are intended to be educational opportunities featuring national and international guest experts who have demonstrated success in securing approvals for pharmaceutical products in the […]